July 10, 2015
Keiji Nakamura, Ph.D. Pharma Forum Institute, Kamakura, Japan First Breakthrough Therapy of HCV Infection with Sovaldi and Harvoni One of the brightest topics in recent therapy in the pharma industry was the eradication of hepatitis C virus (HCV) through inhibition...read more